Introduction {#s1}
============

Necrotrophic fungi including *Botrytis cinerea, Fusarium oxysporum*, and *Alternaria brassicicola* are the largest class of fungal phytopathogens causing serious crop losses worldwide ([@bib43]). These pathogens extract nutrients from dead host cells by producing a variety of phytotoxic compounds and cell wall degrading enzymes ([@bib82]; [@bib55]). *B. cinerea* has a broad host-range, causes pre- and postharvest disease, and is the second most agriculturally important fungal plant pathogen ([@bib17]).

Plant immunity towards *B. cinerea* appears to be under complex poorly understood genetic control ([@bib71]). Apart from the *Arabidopsis thaliana RESISTANCE TO LEPTOSPHAERIA MACULANS 3* (*RLM3*), no major *R-gene* has been associated with resistance to necrotrophs. However, over the past two decades numerous genes that influence the outcome of *B. cinerea*---host interactions have been identified ([@bib55]). Among these are several transcription factors (TFs) consistent with the large transcriptional reprogramming observed in host cells upon *Botrytis* infection ([@bib9]; [@bib8]; [@bib83]). In *Arabidopsis*, several MYB-type TFs regulate distinct host transcriptional responses towards *B. cinerea*. BOS1 (*BOTRYTIS SUSCEPTIBLE 1*)/MYB108 appears to restrict necrosis triggered by *B. cinerea* and *A. brassicicola*, and loss-of-BOS1 function increased plant susceptibility ([@bib55]). In response to stress and *B. cinerea* infection, BOS1 physically interacts with and is ubiquitinated by BOI, a RING E3 ligase that contributes to defense by restricting the extent of necrosis ([@bib49]). MYB51 is involved in the transcriptional activation of indole glucosinolate biosynthetic genes, which also contributes to resistance towards necrotrophs ([@bib39]; [@bib75]). In contrast, the MYB-related genes *ASYMMETRIC LEAVES 1 (AS1)* and *MYB46* appear to play a role in disease susceptibility as such mutants show increased disease resistance towards *B. cinerea* ([@bib60]; [@bib67]).

Ethylene and jasmonic acid (ET, JA) signaling are critical for host immunity to necrotrophic pathogens, and several transcriptional activators and repressors of the ET and JA pathways impact resistance to *B. cinerea* ([@bib24]; [@bib5]). In particular the TFs ERF1, ORA59, ERF5, ERF6, and RAP2.2, have regulatory functions in host susceptibility to this fungus. ([@bib7]; [@bib64]; [@bib58]; [@bib88]). Transgenic *Arabidopsis* lines overexpressing *ERF1* or *ORA59* confer resistance to *B. cinerea* ([@bib37]), whereas *RNAi-ORA59* silenced lines were more susceptible ([@bib7]; [@bib64]). Both ERF1 and ORA59 appear to be the key integrators of the ET- and JA-signaling pathways ([@bib63]). In contrast, the bHLH transcription factor MYC2/JIN1 is a master regulator of diverse JA-mediated responses by antagonistically regulating two distinct branches of the JA signaling pathway in response to necrotrophs ([@bib37]).

The WRKY family of TFs modulates numerous host immune responses ([@bib61]). In particular, WRKY33 is a key positive regulator of host defense to both *A. brassicicola* and *B. cinerea* ([@bib90]; [@bib8]). WRKY33 was directly phosphorylated in vivo by the MAP kinases MPK3 and MPK6 upon *B. cinerea* infection and subsequently activated *PAD3* expression by direct binding to its promoter ([@bib53]). *PAD3* encodes a key biosynthetic enzyme required for the production of the antimicrobial compound camalexin. Moreover, WRKY33 directly interacted with its own promoter, suggesting a positive feedback regulatory loop on *WRKY33* expression. WRKY33 was also found to interact with the VQ-motif containing protein MAP KINASE SUBSTRATE1 (MKS1/VQ21) and to form a ternary complex with the MAP kinase MPK4 within the nucleus of resting cells ([@bib3]; [@bib65]). Upon challenge with the hemibiotrophic pathogen *Pseudomonas syringae* or upon elicitation by the microbe-associated molecular pattern (MAMP) flg22, the active epitope of the bacterial flagella, activated MPK4 phosphorylates MKS1 thereby releasing WRKY33 from the complex and leading to its detection at the *PAD3* promoter.

We previously reported that activation of *Arabidopsis WRKY33* resulted in rapid and massive host transcriptional reprogramming upon infection with *B. cinerea* strain 2100 ([@bib8]). Compared to resistant wild-type (WT) plants, susceptible *wrky33* mutants displayed early inappropriate activation of salicylic acid (SA)-related host responses, elevated SA and JA levels, and down-regulation of JA-associated responses at later infection stages. Consistent with these results ChIP analysis demonstrated that WRKY33 directly binds to the regulatory regions of *JAZ1* and *JAZ5*, two genes encoding repressors of JA signaling, but also to the ERF class TF gene *ORA59* involved in JA-ET crosstalk, and to two camalexin biosynthesis genes *CYP71A13* and *PAD3* ([@bib8]). Although *pad3* plants are susceptible to *B. cinerea* 2100, *wrky33* mutants are more highly susceptible. Genetic studies revealed that altered SA responses at later infection stages may contribute to the susceptibility of *wrky33* to *B. cinerea*, but were insufficient for WRKY33-mediated resistance ([@bib8]). Thus, WRKY33 apparently targets additional genes whose functions are critical for establishing full WRKY33-dependent resistance towards this necrotroph.

In this paper, we performed ChIP-seq and RNA-seq analyses to identify WRKY33-regulated target genes in the *A. thaliana* genome following infection with *B. cinerea* 2100. The study uncovered numerous targets many of which are associated with the regulation of hormonal signaling pathways. Expression of the majority of WRKY33 direct targets is down-regulated upon infection, but some notably genes of camalexin biosynthesis are strongly up-regulated, indicating that WRKY33 is a dual functional TF acting in a promoter-context dependent manner. Subsequent genetic and hormonal studies verified components of abscisic acid (ABA) biosynthesis as being critical for WRKY33-dependent resistance towards this necrotrophic fungus. This study provides the first genome-wide view of the gene regulatory network underlying plant immunity governed by a host specific TF.

Results {#s2}
=======

Genome-wide detection of *Arabidopsis* WRKY33 binding sites in response to *B. cinerea* 2100 {#s2-1}
--------------------------------------------------------------------------------------------

To gain a deeper insight into how WRKY33 regulates plant immunity towards *B. cinerea* 2100, we performed ChIP-seq for genome-wide in vivo identification of WRKY33 DNA-binding sites. For this, a transgenic *wrky33* null mutant expressing an HA epitope-tagged *WRKY33* construct under the control of its native promoter (*P*~*WRKY33*~*:WRKY33-HA*) was used. This line complemented the *B. cinerea* 2100 susceptibility phenotype of *wrky33* plants resulting in resistance similar to WT Col-0 plants ([@bib8]). Rosette leaves of 4-week old plants, mock treated or spray inoculated with spores of *B. cinerea* 2100, were collected at 14 hr post inoculation and used to perform ChIP-seq. The 14 hr timepoint was selected based on the induced WRKY33-HA protein levels observed in western blots ([Figure 1A](#fig1){ref-type="fig"}). No WRKY33-HA protein was detected in the absence of infection. Besides the non-induced sample, we used identically treated WT plant tissue lacking *WRKY33-HA* as an additional negative control. Two biological replicates each were analyzed. The previously identified WRKY33 in vivo target genes, *CYP71A13* and *PAD3*, were used to monitor by ChIP-qPCR specific enrichment in samples used for library construction and sequencing ([@bib8]).10.7554/eLife.07295.003Figure 1.Genome-wide identification of *Arabidopsis* WRKY33 binding sites.(**A**) Western-blot analysis of WRKY33-HA protein levels after mock treatment or spray-inoculation of *P*~*WRKY33*~*:WRKY33-HA* transgenic plants with *B. cinerea* 2100 spores. Plant material selected for ChIP-seq is boxed. (**B**) Relative binding-peak distribution across genomic regions. The 1 kb region upstream of the transcription start site is defined as promoter. The fraction of nucleotides in the complete At genome associated with each annotation type is included in the figure as background control (At genome). (**C**) Distribution of identified WRKY33 binding sites relative to the TSS. (**D**) Conserved DNA elements enriched within the 500 bp WRKY33 binding peak regions identified by DREME motif search. The TTGACT/C motif represents the well-established W-box, whereas T/GTTGAAT is an identified new motif.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.003](10.7554/eLife.07295.003)10.7554/eLife.07295.004Figure 1---figure supplement 1.Conserved DNA elements within the 500 bp WRKY33 binding peak summit regions identified by MEME.(**A**) W-box with 5′ extended motifs. (**B**) W-box with 3′ extended motifs. (**C**) Additional conserved sequence GACTT/ATTC element. (**D**) Venn diagram illustrating the number of overlapping peaks containing both the W-box and the newly identified motif T/GTTGAAT.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.004](10.7554/eLife.07295.004)10.7554/eLife.07295.005Figure 1---figure supplement 2.WRKY33 does not bind to the G/TTTGAAT motif.EMSA was performed using recombinant WRKY33 and biotin labeled DNA probes. A DNA oligonucleotide containing 3 W-box elements ([@bib53]) or a W-box mutated version (W-boxmut) hereof served as a positive and as a negative control, respectively (**A**). The 45 bp M-3 was derived from the *PROPEP3* (At5g64905) gene promoter and contained three copies of the G/TTTGAAT motif, whereas the 40 bp M-7 was derived from the *WAKL7* (At1g16090) gene promoter and contained one G/TTTGAAT motif. No binding of WRKY33 was observed to the W-boxmut probe and to both the M-3 and M-7 probes (**B**). Specificity of W-box binding was shown by competition assays using 250-fold (W-box) and 500-fold (W-box; M-3, M-7) excess of unlabeled probes. Protein lysates derived from IPTG-induced bacteria harboring the empty expression vector pMCSG48 served as an additional control.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.005](10.7554/eLife.07295.005)

We identified 1684 high confidence WRKY33 binding sites common to both replicates, which are associated with 1576 genes ([Figure 2C](#fig2){ref-type="fig"}*,* [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). WRKY33 binding to all detected sites was dependent on prior infection with *B. cinerea* 2100. Over 78% of the identified peak regions were located in promoter (1 kb region upstream of the transcription start site) or 5′ intergenic regions ([Figure 1B](#fig1){ref-type="fig"}) and 15.4% were located near transcription termination sites. Less than 1% and 5% of the peaks were located in exons and intronic regions, respectively ([Figure 1B](#fig1){ref-type="fig"}). The genome-wide local distribution of peak regions relative to genes showed clear accumulation of WRKY33 binding at about −300 bp from the transcription start sites ([Figure 1C](#fig1){ref-type="fig"}). The fidelity of the ChIP-seq data was subsequently confirmed by ChIP-qPCR for a number of genes ([Supplementary file 2](#SD2-data){ref-type="supplementary-material"}). Moreover, nearly all previously reported WRKY33 in vivo targets including *PAD3, CYP71A13, ACS2, JAZ1, ORA59, TRX-h5,* and *WRKY33* itself were successfully identified in our ChIP-seq dataset ([@bib53]; [@bib8]; [@bib46]).10.7554/eLife.07295.006Figure 2.WRKY33-regulated direct target genes in response to ***B****. cinerea* 2100 infection.(**A**) Number of differentially expressed genes (≥ twofold; p ≤ 0.05) between WT and *wrky33* (*w33*) at 14 hr after mock treatment (mo) or spray inoculation with spores of *B. cinerea* 2100 (*B.c*.) identified by RNA-seq. Indicated are total numbers (boxed) and numbers of up-regulated (![](elife07295inf001.jpg)) and down-regulated genes (![](elife07295inf002.jpg)) between treatments or genotypes. (**B**) Venn diagram illustrating the total numbers and the number of common genes affected in WT and *wrky33* 14 hr post *B. cinerea* 2100 inoculation. (**C**) Venn diagram showing the numbers of genes common to WRKY33-regulated genes and WRKY33 target genes. (**D**) Percentage of WRKY33-repressed and WRKY33-induced target genes (in total 318). (**E**) Enrichment of specific Gene Ontology (GO) terms related to defense response, kinase activity, cell death, and hormone responses among WRKY33-regulated target and non-target genes (compared to the overall genome). The y-axis indicates the percentages of genes associated to each GO category in each gene set. Asterisks indicate significant enrichment (adj. p value \< 0.05) of genes associated to the respective GO term within a gene set as determined by GO term enrichment analysis with goseq (null distribution approximated as Wallenius distribution; correction for potential count biases via probability weighting).**DOI:** [http://dx.doi.org/10.7554/eLife.07295.006](10.7554/eLife.07295.006)10.7554/eLife.07295.007Figure 2---figure supplement 1.GO graph visualization of top GO terms enriched among WRKY33-regulated WRKY33 target genes.(**A**) GO sub-graph induced by the top 10 GO terms in the category 'Biological Process'. (**B**) GO sub-graph induced by the top 5 GO terms in the category 'Molecular Function'. Boxes indicate the 10 (**A**) and 5 (**B**) most significant terms, respectively. Box color represents the relative significance, ranging from dark red (most significant) to light yellow (least significant). GO term enrichment was determined using goseq, with the null distribution approximated as Wallenius distribution and correcting for potential count biases via probability weighting.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.007](10.7554/eLife.07295.007)10.7554/eLife.07295.008Figure 2---figure supplement 2.Analysis of WRKY33-regulated target genes associated to GO-terms 'hormone responses and cell death'.(**A**) Venn diagram showing the overlap between the WRKY33-regulated target genes responsive to SA and associated with cell death. (**B**) The overlap of WRKY33-regulated target genes associated with the hormone pathways SA, ET, ABA, and JA.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.008](10.7554/eLife.07295.008)

Numerous studies have revealed that WRKY proteins specifically bind to a DNA motif, TTGACT/C, termed the W-box ([@bib72]), although adjacent bases (W-box extended motifs) can also influence binding ([@bib13]). Using the DREME/MEME software, we determined conserved consensus sequences within high confidence WRKY33 binding sites across the genome. Of the 1684 identified WRKY33 binding regions, 80% contained the well-established W-box motif ([Figure 1D](#fig1){ref-type="fig"}). We also found W-box extended sequence motifs within the WRKY33 binding regions ([Figure 1---figure supplement 1A,B](#fig1s1){ref-type="fig"}). These W-box extended motifs also included the core sequence GACTTTT ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}), which was reported to be bound by *Arabidopsis* WRKY70 and to be required for WRKY70-activated gene expression ([@bib51]).

Apart from the W-box and W-box variants, we found one additional sequence motif, T/GTTGAAT that occurs in 60% of the WRKY33 binding regions ([Figure 1D](#fig1){ref-type="fig"}). More than 48% (817 out of 1684) of WRKY33 binding peaks contained both this new motif and the W-box ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}). We performed electrophoresis mobility shift assays (EMSA) using recombinant WRKY33 protein to determine whether this newly identified DNA element is bound by WRKY33. Two DNA oligonucleotide probes were synthesized whose sequences were derived from two WRKY33 targets (*WAKL7, PROPEP3*) containing either one or three copies of the motif, respectively. A previously described DNA oligonucleotide containing three W-boxes ([@bib53]) and a W-box mutated version hereof W-boxmut served as positive and negative controls. A clear interaction (mobility shift) was observed between WRKY33 and the labeled W-box probe but not with W-boxmut and the two probes harboring the T/GTTGAAT motifs (M-3 and M-7; [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Specificity of W-box binding was confirmed in competition experiments, wherein only an excess of the W-box probe was able to compete for binding of the protein. Thus, T/GTTGAAT does not appear to be a WRKY33 direct binding site and its functionality remains unclear.

Differential expression of WRKY33 target genes upon *B. cinerea* 2100 infection {#s2-2}
-------------------------------------------------------------------------------

ChIP-seq studies in different organisms have revealed that the majority of binding sites bound by specific TFs in vivo do not result in altered expression levels of associated genes ([@bib52]; [@bib11]; [@bib19]). To investigate the impact of WRKY33 binding on target gene expression, we performed RNA-seq and examined *WRKY33*-mediated gene expression changes in mock and *B. cinerea* 2100 (14 hpi) treated 4-week old *wrky33* and WT plants. Three independent biological replicates were generated and analyzed allowing us to identify genes with consistently altered expression after inoculation. In WT plants, the expression of 6101 genes was altered twofold or more (p ≤ 0.05) compared to non-infected plants, with 3048 genes being up-regulated and 3053 genes being down-regulated ([Figure 2A](#fig2){ref-type="fig"}). In *wrky33*, upon infection, the expression of 7441 genes was altered more than twofold, 3583 of them being up-regulated and 3858 down-regulated. A common set of 4686 genes showed changes upon infection in both genotypes ([Figure 2A,B](#fig2){ref-type="fig"}). Comparative profiling of mock treated plants identified 705 genes that were differentially expressed between *wrky33* and WT in the absence of the pathogen, 458 of them being up-regulated and 247 down-regulated ([Figure 2A](#fig2){ref-type="fig"}). Comparing the expression profiles of *B. cinerea* infected *wrky33* and WT plants (*wrky33 B.c* vs WT *B.c*), we identified 2765 differentially expressed genes dependent on WRKY33, of which 1675 were up-regulated in the mutant (termed WRKY33-repressed genes) and 1090 were down-regulated in the mutant (termed WRKY33-induced genes; [Figure 2A,C](#fig2){ref-type="fig"}).

We then compared the WRKY33-dependent differentially expressed gene set obtained by RNA-seq with the WRKY33 target gene set revealed by ChIP-seq. This comparison identified 318 WRKY33-regulated target genes that were both bound by WRKY33 and exhibited WRKY33-dependent altered gene expression ([Figure 2C](#fig2){ref-type="fig"}). Of these, 240 (75%) were repressed upon infection while 78 (25%) were induced ([Figure 2C,D](#fig2){ref-type="fig"}). We named those genes WRKY33-repressed targets and WRKY33-induced targets, respectively. Based on this analysis, WRKY33 appears to have a prominent repressive role on the transcription of many specific host genes indicating a negative regulatory function of WRKY33 in mediating immunity to this pathogen. Genes displaying altered expression in the *wrky33* mutant compared to WT but showing no binding of WRKY33 at their respective gene loci were defined as WRKY33-dependent non-targets (1435 WRKY33-repressed non-targets and 1012 WRKY33-induced non-targets; [Figure 2C](#fig2){ref-type="fig"}). The overlap between observed WRKY33 binding and altered expression of the associated genes upon fungal infection was around 20% (318 of 1576). This fraction is similar to values reported for other plant TFs such as EIN3, HBI1, and BES1 ([@bib86]; [@bib11]; [@bib19]).

WRKY33 represses transcription of many plant immunity genes {#s2-3}
-----------------------------------------------------------

Compared to the entire genome the identified WRKY33-regulated targets were significantly enriched in gene onthology (GO) categories involved in diverse biological processes and molecular functions related to different forms of stress, external and endogenous stimuli, signal transduction, transport, metabolic processes and catalytic activity (p \< 0.05; [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), and many of these genes are repressed upon *B. cinerea* infection ([Figure 2E](#fig2){ref-type="fig"}). For example, genes related to 'defense response' were highly overrepresented among WRKY33-repressed targets (38%) and in the WRKY33-repressed non-target sets (17%), suggesting that WRKY33 mainly functions as a repressor of plant defense responses. However, it is important to note that nearly 18% of the WRKY33-induced targets were associated to defense responses compared to only 3% of the WRKY33-induced non-targets. This indicates that WRKY33 can also act as a direct activator of defense gene expression, very likely in a promoter-context dependent manner. Particularly prominent among the WRKY33-induced targets are genes associated with responses to the phytohormone ethylene (ET; 21%).

Apart from hormonal pathways discussed below, genes associated with the GO terms 'cell death' or related to diverse 'kinase activities' were markedly enriched among WRKY33-repressed targets and non-targets ([Figure 2E](#fig2){ref-type="fig"}). 42 out of 318 WRKY33-regulated targets are involved in cell death, and 38 of these appear to be repressed by WRKY33 ([Supplementary file 3](#SD3-data){ref-type="supplementary-material"}). This WRKY33-mediated repression may be an important feature required to reinforce resistance towards the necrotroph *B. cinerea* that depends on dead host tissue to complete its life cycle. Furthermore, 41 of the WRKY33-regulated target genes encode for various kinases, and again the majority of these genes appear to be negatively regulated by WRKY33 ([Supplementary file 4](#SD4-data){ref-type="supplementary-material"}). For the WRKY33-regulated target *LecRK VI.2*, a critical role in resistance against hemibiotrophic *P. syringae* pv. tomato DC3000 and necrotrophic *Pectobacterium carotovorum* bacteria has been demonstrated ([@bib78]; [@bib32]).

Several TF gene families involved in defense were targeted by WRKY33. In total, WRKY33 binding was found at 133 TF gene loci. Predominant among these are members of the AP2/ERFs, MYBs, WRKYs, and NACs families ([Figure 3A](#fig3){ref-type="fig"}). However, expression of only 16% (21 of 133) of these genes was directly modulated in a WRKY33-dependent manner after *B. cinerea* infection (complete list see [Supplementary file 5](#SD5-data){ref-type="supplementary-material"}). WRKY factors are predicted to form a highly interconnected regulatory sub-network ([@bib48]). Indeed, 18 *WRKY* genes were identified as direct targets of WRKY33 ([Figure 3A](#fig3){ref-type="fig"}). However, only seven genes, *WRKY33, WRKY38, WRKY41, WRK48, WRKY50, WRKY53,* and *WRKY55,* showed altered expression upon WRKY33 binding at 14 or 24 hpi ([Figure 3B--G](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}*,* [Supplementary file 5](#SD5-data){ref-type="supplementary-material"}). Binding to the *WRKY33* promoter is consistent with reports suggesting a positive autoregulatory feedback loop resulting in high-level accumulation of WRKY33 in response to *B. cinerea* ([@bib53]). In addition, WRKY33-dependent altered transcription of 18 other *WRKY* genes with no detectable WRKY33 binding was observed following fungal infection, indicating that these genes are indirectly regulated by WRKY33 (WRKY33-regulated non-targets; [Figure 3A](#fig3){ref-type="fig"}). WRKY33 function negatively affected expression of most of these *WRKY* targets.10.7554/eLife.07295.009Figure 3.WRKY33-regulated transcription factor families commonly associated with stress responses.(**A**) WRKY, MYB, NAC, and AP2/ERF TF family genes are dominant targets of WRKY33 after *B. cinerea* 2100 infection. The total number of members for each TF family is given in parenthesis next to name. The number of WRKY33 directly or indirectly regulated family members are indicated. (**B**, **C**) Integrative Genomics Viewer (IGV) images of ChIP-seq data revealing high infection-dependent WRKY33 binding at the promoters of *Arabidopsis WRKY33* (**B**) and *WRKY41* (**C**). Images for mock and *B.c*. treatment of both biological repetitions are shown (1 and 2). Structure of the targeted genes is indicated below along with the position of all W-box motifs within the loci. Arrows indicate direction of transcription. (**D**, **E**) qRT-PCR analysis of *B. cinerea* 2100-induced expression of *WRKY33* (**D**) and *WRKY41* (**E**) in WT and *wrky33* mutant plants at indicated time points post fungal spore application. All data were normalized to the expression of At4g26410 and fold induction values of all genes were calculated relative to the expression level of mock treated (mo) WT plants set to 1. Error bars represent SD of three biological replicates. Asterisks indicate significant differences between WT and *wrky33* (\*, p \< 0.05; \*\*, p \< 0.001; two-tailed *t*-test). (**F**, **G**) Validation of ChIP-seq data by ChIP-qPCR showing WRKY33 binding to its own promoter region (**F**) and to the *WRKY41* promoter (**G**). WRKY33-HA (33HA) plants were spray inoculated with spores of *B. cinerea* 2100 (Bc) or mock treated (mo) for 14 hr. Input DNA before immune precipitation (IN) and immune-precipitated DNA using an anti-HA antibody (IP) was analyzed by qPCR employing gene-specific primer pairs (p) indicated in the IGV graph. Shown is the fold enrichment of bound DNA relative to a non-bound DNA fragment from At2g04450. As a control for primer efficiency purified genomic DNA was included in the analysis. Each ChIP experiment was repeated at least twice with similar results.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.009](10.7554/eLife.07295.009)10.7554/eLife.07295.010Figure 3---figure supplement 1.Validation of WRKY33 directly regulated *WRKY* genes.Shown for each of the *WRKY* genes *38* (**A**)*, 48* (**B**)*, 50* (**C**)*, 53*(**D**)*,* and *55* (**E**), are; (i) the ChIP-seq data, visualized in the IGV browser, revealing strong infection-dependent WRKY33 enrichment at the corresponding promoter, (ii) qRT-PCR analysis of *B. cinerea* 2100-induced expression of the respective *WRKY* gene in WT and *wrky33* at indicated time points post spore inoculation, and (iii) ChIP-qPCR confirmation of WRKY33 binding to the respective *WRKY* promoter. Amplicons used are indicated in the IGV images (p, p1, p2, p3). For detailed descriptions on how qRT-PCR and ChIP-qPCR were performed see legend to [Figure 3](#fig3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.010](10.7554/eLife.07295.010)

WRKY33 modulates transcription of genes associated with hormonal pathways {#s2-4}
-------------------------------------------------------------------------

Genes encoding components of pathways related to the key phytohormone signaling molecules SA, JA, ET, and ABA were highly enriched in the WRKY33-regulated gene set ([Figure 2E](#fig2){ref-type="fig"}). Genes involved in SA response were overrepresented in WRKY33-repressed targets and non-targets ([Figure 2E](#fig2){ref-type="fig"}). This is consistent with our previous transcriptomic profiling showing that WRKY33 directly or indirectly repressed the expression of genes in SA biosynthesis and SA-mediated signaling ([@bib8]). More than 80% (34 out of 42) of the SA-response targets are also associated with the GO term 'cell death' ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}), suggesting that WRKY33 repression of the SA pathway is linked to modulation of host cell death responses.

In contrast to SA signaling genes, genes responsive to ET were highly enriched in the WRKY33-induced target dataset, among them are *ACS6*, *ORA59*, and *ERF5* ([Figure 2E](#fig2){ref-type="fig"}). ACS6 is involved in *Botrytis*-induced ethylene production and plays an important role in plant immunity ([@bib29]; [@bib46]). ORA59 and ERF5 belong to the AP2/ERF TF family with ORA59 acting as an integrator of JA and ET signaling and as a positive regulator of resistance against *B. cinerea*, while ERF5 also regulates ET signaling and is a key component of chitin-mediated immunity ([@bib64]; [@bib58]). Genes responsive to JA and ABA were also overrepresented in our GO term analysis, but in this case similar fractions of genes were identified among WRKY33-induced targets, WRKY33-repressed targets and WRKY33-repressed non-targets ([Figure 2E](#fig2){ref-type="fig"}). Some WRKY33-regulated targets were associated to more than one hormone response ([Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"}), suggesting the involvement of WRKY33 in hormonal co-regulation or crosstalk.

In conclusion, our global analysis revealed that WRKY33 influences various hormonal responses upon infection with *B. cinerea* 2100, and that WRKY33 had both a positive and a negative functional relationship with a fraction of its direct targets.

WRKY33-dependent resistance to *B. cinerea* 2100 involves ABA {#s2-5}
-------------------------------------------------------------

Our previous genetic analyses excluded a major role of SA, JA and ET signaling in WRY33-dependent resistance towards *B. cinerea* 2100 ([@bib8]). Here, two additional genes, *GH3.2* and *GH3.3*, encoding acyl-acid-amide synthetases capable of conjugating amino acids to JA and auxin were identified as being WRKY33-repressed targets ([Figure 8---figure supplement 3A](#fig8s3){ref-type="fig"}). GH3.3 controls JA homeostasis in seedlings, and *gh3.2* mutants showed increased resistance to *B. cinerea* ([@bib26]; [@bib28]). Thus, we generated *wrky33 gh3.2 gh3.3* triple mutant plants but did not observe restoration of WT-like resistance towards *B. cinerea* 2100, indicating that they are not critical for WRKY33-dependent defense against this fungal strain ([Figure 8---figure supplement 3B](#fig8s3){ref-type="fig"}).

Interestingly, our global binding studies also revealed that WRKY33 binds to the promoter region of *NCED3* and to the 3′UTR region of *NCED5* ([Figure 4A,D](#fig4){ref-type="fig"}), two major genes encoding 9-cis-epoxycarotenoid dioxygenase, a key enzyme in the biosynthesis of ABA ([@bib44]). The precise role of ABA in host defense remains enigmatic and ABA can positively or negatively impact the outcome of plant--microbe interactions, depending on the pathogens\' lifestyle ([@bib69]). WRKY33 binding to both gene loci was confirmed by ChIP-qPCR ([Figure 4C,F](#fig4){ref-type="fig"}). Transcript levels of *NCED3* and *NCED5* both increased in the *wkry33* mutant upon *B. cinerea* infection suggesting direct negative regulation by WRKY33 ([Figure 4B,E](#fig4){ref-type="fig"}). WRKY33 also bound to the *CYP707A3* promoter, a gene involved in ABA catabolism ([@bib44]), but its expression decreased in the *wrky33* mutant and increased in WT plants after infection indicative of positive regulation by WRKY33 ([Figure 4G--I](#fig4){ref-type="fig"}).10.7554/eLife.07295.011Figure 4.WRKY33 directly regulates target genes encoding ABA biosynthetic (*NCED3, NCED5*) and metabolic (*CYP707A3*) enzymes by binding to their promoters or 3′UTR after *B. cinerea* 2100 treatment.(**A**, **D**, **G**) IGV visualization of ChIP-seq data revealing infection-dependent WRKY33 enrichment at the *Arabidopsis NCED3* (**A**), *NCED5* (**D**) and *CYP707A3* (**G**) loci with features described in [Figure 3](#fig3){ref-type="fig"}. (**B**, **E**, **H**) qRT-PCR analysis of *B. cinerea* 2100-induced expression of *NCED3* (**B**) *NCED5* (**E**) and *CYP707A3* (**H**) in WT and *wrky33* as described in [Figure 3](#fig3){ref-type="fig"}. (**C**, **F**, **I**) Validation of the ChIP-seq data for WRKY33 binding to the promoters of *NCED3* (**C**, with primer pairs p1 and p2) and *CYP707A3* (**I**), and to the 3′UTR of *NCED5* (**F**) performed as described the legend to [Figure 3](#fig3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.011](10.7554/eLife.07295.011)

These results suggest that WRKY33 represses ABA levels during *B. cinerea* 2100 infection, and that this repressor function is an important component in host resistance to this pathogen.

Negative regulation of *NCED3* and *NCED5* by WRKY33 contributes to resistance to *B. cinerea* 2100 {#s2-6}
---------------------------------------------------------------------------------------------------

To clarify the involvement of ABA in WRKY33-mediated host defense to *B. cinerea* 2100, we analyzed ABA mutants with respect to their phenotypes after fungal infection. Previous reports have shown that *aba2-12* ([@bib1]), *aba3-1* ([@bib45])*,* and *nced3 nced5* ([@bib21]) accumulated much less ABA than WT plants. Indeed, the *aba2-12, aba3-1, nced3-2, nced5-2,* and *nced3 nced5* mutants were nearly as resistant as WT plants *to B. cinerea* 2100 ([Figure 5B](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). To test whether WT resistance towards this necrotroph is due to WRKY33-mediated repression of *NCED3* and *NCED5* expression we generated *wrky33 nced3*, *wrky33 nced5* double, and *wrky33 nced3 nced5* triple mutants, and tested their infection phenotypes.10.7554/eLife.07295.012Figure 5.WRKY33 controls ABA-mediated plant susceptibility to *B. cinerea* 2100.(**A**) Growth phenotypes of WT, *wrky33*, *nced3 nced5*, and *wrky33 nced3 nced5 Arabidopsis* plants at 4 weeks under short day conditions. (**B**) *B. cinerea* infection phenotypes 3 days post inoculation of WT, *wrky33*, *nced3*, *nced5*, *nced3 nced5*, and *wrky33 nced3 nced5*. (**C**) *B. cinerea* biomass quantification on indicated *Arabidopsis* genotypes. For fungal biomass determination, the relative abundance of *B. cinerea* and *Arabidopsis* DNA was determined by qPCR employing specific primers for *Bc*Cutinase A and *At*SKII, respectively. (**D**) Exogenous application of ABA (10 μM) directly to infection droplets on *wrky33 nced3 nced5* leaves partially rendered plants susceptible to *B. cinerea* 2100. Upon completion of the infection experiments (3 dpi), leaves were detached and photographed. For the infections, one or two 2 μl droplets containing 2.5 × 10^5^ spores were applied to each leaf.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.012](10.7554/eLife.07295.012)10.7554/eLife.07295.013Figure 5---figure supplement 1.*B. cinerea* 2100 infection phenotypes of mature 4-week old leaves derived from *aba2-12* and *aba3-1* mutant plants.Pictures were taken 3 days post inoculation of two 2 μl droplets containing 2.5 × 10^5^ spores to each leaf (leaves were detached after completion of the experiment for photographic purposes only).**DOI:** [http://dx.doi.org/10.7554/eLife.07295.013](10.7554/eLife.07295.013)10.7554/eLife.07295.014Figure 5---figure supplement 2.*B. cinerea* 2100 infection phenotypes of mature 4-week old leaves derived from *wrky33 nced3* and *wrky33 nced5* mutant plants.Pictures were taken 3 days post inoculation of two 2 μl droplets containing 2.5 × 10^5^ spores to each leaf (leaves were detached after completion of the experiment for photographic purposes only).**DOI:** [http://dx.doi.org/10.7554/eLife.07295.014](10.7554/eLife.07295.014)10.7554/eLife.07295.015Figure 5---figure supplement 3.Phenotype of WT Col-0 plants treated with ABA.Infection droplets with ABA (10 μM; red arrows) or without ABA (black arrows) were applied to 4-week old leaves. No alteration of the WT resistant phenotype was observed. Picture was taken 3 days post inoculation of two 2 μl droplets containing 2.5 × 10^5^ spores to each leaf.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.015](10.7554/eLife.07295.015)10.7554/eLife.07295.016Figure 5---figure supplement 4.*B. cinerea* 2100 infection phenotypes of mature 4-week old leaves derived from cyp707a1, *cyp707a2* and *cyp707a3* mutant plants.Pictures were taken 3 days post inoculation of two 2 μl droplets containing 2.5 × 10^5^ spores to each leaf (leaves were detached after completion of the experiment for photographic purposes only).**DOI:** [http://dx.doi.org/10.7554/eLife.07295.016](10.7554/eLife.07295.016)

ABA deficiency severely affects plant growth leading to stunted phenotypes, as observed in *nced3 nced5, aba2-12* and *aba3-1* mutants. A strong reduction of rosette diameter was also observed in the *wrky33 nced3 nced5* mutant under short day conditions ([Figure 5A](#fig5){ref-type="fig"})*.* However, unlike the *wrky33* mutant, the *wrky33 nced3 nced5* triple mutant showed clear resistance to *B. cinerea* 2100 similar to WT plants ([Figure 5B](#fig5){ref-type="fig"}). In contrast, the *wrky33 nced3* and *wrky33 nced5* double mutants were as susceptible as *wrky33* ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). Consistent with the observed resistance phenotype, qPCR analysis revealed strongly reduced fungal biomass in *wrky33 nced3 nced5* compared to *wrky33* plants at 3 days post infection ([Figure 5C](#fig5){ref-type="fig"})*.* This clearly indicates that increased expression levels of *NCED3* and *NCED5* in the *wrky33* mutant contribute to susceptibility toward *B. cinerea* 2100, and that a key function of WRKY33 in host immunity towards this pathogen is to repress ABA biosynthesis.

Since *nced3 nced5* mutants have reduced ABA levels, we tested whether exogenous application of ABA to the mutants could revert the resistant phenotype. Indeed, application of ABA together with the fungal spore droplet to leaves of the *wrky33 nced3 nced5* triple mutant partially rendered plants susceptible to *B. cinerea* 2100 ([Figure 5D](#fig5){ref-type="fig"}). Similar tests on WT plants did not alter host resistance ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}).

*CYP707A* mutants affecting ABA metabolism were reported to accumulate more ABA than lines overexpressing ABA biosynthetic genes ([@bib20]). We therefore also tested the phenotypes of *cyp707a1, cyp707a2, and cyp707a3* following infection*.* Interestingly, all of these mutants remained as resistant as WT plants towards the fungus ([Figure 5---figure supplement 4](#fig5s4){ref-type="fig"}).

Taken together, our genetic analysis combined with our ChIP-seq and expression results strongly suggests that WRKY33-mediated control of *NCED3* and *NCED5* expression plays a critical role in host resistance towards *B. cinerea* 2100.

WRKY33 controls hormone homeostasis in response to *B. cinerea* {#s2-7}
---------------------------------------------------------------

Hormonal signaling appears to be affected in the susceptible *wrky33* mutant compared with the resistant WT ([Figure 2E](#fig2){ref-type="fig"}), and *wrky33 nced3 nced5* triple mutants restore WT-like resistance. Thus, we hypothesized that WRKY33 plays a critical regulatory role in hormone homeostasis. To test this, we measured hormonal levels in WT*, wrky33*, *nced3 nced5*, and *wrky33 nced3 nced5* plants following infection with *B. cinerea* 2100 at various time points*.* It is important to note that we have previously shown that up to 40 to 48 hpi no differences in fungal biomass, hyphal expansion, or other phenotypic criteria were observed between resistant WT and susceptible *wrky33* plants ([@bib8]).

As expected, ABA and SA levels increased strongly in susceptible *wrky33* compared to resistant WT plants during fungal infection ([Figure 6A,B](#fig6){ref-type="fig"}). However, JA and ACC (precursor of ET) levels also increased strongly in *wrky33* compared to WT plants ([Figure 6C,D](#fig6){ref-type="fig"}). Interestingly, the elevated SA levels observed in *wkry33* appear to be a direct consequence of increased ABA levels as SA levels were clearly reduced in the resistant ABA-deficient *wrky33 nced3 nced5* compared to *wrky33* plants post infection. Moreover, the levels of JA and ACC were also reduced in *wrky33 nced3 nced5* at later infection stages. This suggests that ABA signaling exerts a positive role on the biosynthesis of these other hormonal components.10.7554/eLife.07295.017Figure 6.Hormone levels in different genotypes during *B. cinerea* 2100 infection.Concentrations of the hormones ABA (**A**), SA (**B**), ACC (**C**), and JA (**D**) were measured at 8, 14, 24, and 40 hpi in leaves of indicated *Arabidopsis* genotypes spray inoculated with spores of *B. cinerea* 2100. Mock treated plants (mo, 14 hr) served as a control. The data show the average values and SDs of the combined data from three independent experiments with up to four replicates each.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.017](10.7554/eLife.07295.017)

Taken together, our data indicate that a key function of WRKY33 in *B. cinerea* strain 2100 challenged WT plants is to limit ABA levels. Loss of *WRKY33* function affects hormonal homeostasis in the plant during infection, leading to elevated ABA activity and subsequently resulting in altered hormone signaling.

In *wrky33 nced3 nced5* plants, expression of many up-regulated genes in *wrky33* is restored to WT-like levels {#s2-8}
---------------------------------------------------------------------------------------------------------------

Over 75% of WRKY33-regulated target genes showed elevated expression in the susceptible *wrky33* mutant after *B. cinerea* 2100 infection ([Figure 2D](#fig2){ref-type="fig"}). To test these genes for altered expression in resistant *wrky33 nced3 nced5* plants, we performed qRT-PCR analyses. The transcript levels of several highly expressed SA-related genes observed in *wrky33* at 24 hpi decreased in the *wrky33 nced3 nced5* plants, often returning to WT states. These included: *ICS1, NPR1, NPR3, NPR4, TRX-h5,* and *FMO1* ([Figure 7](#fig7){ref-type="fig"}). However, not all SA-related genes were similarly affected as illustrated for *EDS1, PAD4*, *NIMIN1*, *PR1,* and *PR2*, whose expression levels remained significantly higher than in WT ([Figure 7](#fig7){ref-type="fig"}). These results imply that simultaneous mutations of *NCED3* and *NCED5* in the *wrky33* genotype partially impair SA biosynthesis and signaling.10.7554/eLife.07295.018Figure 7.Expression of numerous genes up-regulated in infected *wrky33* plants showing WT-like levels in the *wrky33 nced3 nced5* triple mutant.Heatmap showing expression levels of genes, differentially expressed in RNA-seq and analyzed by qRT-PCR in WT, *wrky33* (*w33*)*, nced3 nced5* (*n3n5*)*,* and *wrky33 nced3 nced5* (*w33n3n5*) after mock treatment or 24 hr post *B. cinerea* (*B.c*. 2100) infection. Genes showing high expression levels in *wrky33* but reduced levels in the triple mutant are boxed. All values were normalized to the expression of At4G26410.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.018](10.7554/eLife.07295.018)

Reduced transcript levels were also observed for other genes in the *wrky33 nced3 nced5* mutant at 24 hpi such as the TF genes *ERF1*, *NAC019, NAC055, NAC061*, *NAC090, WRKY41, WRKY48, WRKY53,* and *WRKY55*, indicating a positive effect of ABA on their expression ([Figure 7](#fig7){ref-type="fig"}). In contrast, expression of *WRKY38* and *WRKY50* increased in *wrky33 nced3 nced5* plants to even higher levels than observed in *wrky33* ([Figure 7](#fig7){ref-type="fig"}) suggesting a negative effect of ABA on these genes.

The *Botrytis*-induced expression of other ABA response genes including *ACS2*, *BIR1, CDPK1, MPK11,* and *CRK36* was also restored to WT levels in the *wrky33 nced3 nced5* mutant ([Figure 7](#fig7){ref-type="fig"}). Interestingly, *CDPK1, MPK11, CRK36,* and *NPR3* are also responsive to SA and these genes are associated with the GO term 'cell death', suggesting that ABA has a positive effect on cell death responses ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}, [Supplementary files 3, 4](#SD3-data SD4-data){ref-type="supplementary-material"}).

In summary, WRKY33 suppresses the expression of many of its target genes by negatively regulating ABA responses. The subset of genes showing restoration of WT-like expression levels in the resistant triple mutant constitutes prime candidates whose functions may be causal for WRKY33-mediated resistance against this necrotrophic fungus.

Discussion {#s3}
==========

Signal transduction to the nucleus and a complex gene regulatory network governing the massive transcriptional reprogramming in the host upon pathogen perception drive the plant immune response. TFs are key terminal components of this signaling cascade and function by activating and repressing the expression of numerous defense-associated genes. The TF WRKY33 plays a major role in conferring resistance of *Arabidopsis* plants to the fungal necrotroph *B. cinerea*. In the present work, combined genome-wide binding studies and transcriptional analyses allowed us to identify WRKY33 binding sites within the *Arabidopsis* genome upon fungal infection, and to correlate WRKY33 binding to altered transcriptional outputs. By including appropriate mutants in this study, we identified components of the ABA hormonal pathway that act downstream of WRKY33 to mediate host resistance.

Such a genome-wide analysis of in vivo target sites for a selected TF expressed under its native promoter in intact pathogen-infected plant tissue has not yet been reported. Thus, in a broader perspective, this study also sets the framework for establishing a comprehensive gene regulatory network model of plant immunity.

The number of high-affinity WRKY33 binding sites within the genome by far exceeds the number of direct WRKY33 target genes affected in their transcriptional response during *B. cinerea* infection. Overall, 80% of the WRKY33 targets were not significantly differentially expressed in the *wrky33* mutant upon infection compared to WT. This excess number of gene loci bound by a given TF but unaffected in their expression is consistent with previous ChIP-seq studies although the reasons for this discrepancy remain to be elucidated ([@bib52]). One plausible explanation may be that transcriptional activation/repression at specific promoter sites is context dependent, and may require, apart from WRKY33 binding, additional diverse signaling inputs. For example, we detected strong enrichment of WRKY33 within the promoters of numerous genes coding for receptors of various MAMPs and damage-associated molecular patterns (DAMPs) including *FLS2*, *EFR*, *CERK1, PEPR1*, and *PEPR2*, but no altered expression of these genes in the *wrky33* mutant upon *Botrytis* infection. *WRKY33* is also strongly and rapidly induced during MAMP/DAMP-triggered immunity ([@bib47]; [@bib84]), and thus a regulatory function of WRKY33 at these promoters may require additional signals/co-factors only triggered during MAMP/DAMP signaling. Additionally, spatial and temporal differences in the activation of target genes need to be considered. The current paper provides a snapshot of global WRKY33 function during *Botrytis* infection. Whether WRKY33 binding results in temporally distinct transcription patterns, as was observed for EIN3 in the ethylene response, remains to be investigated ([@bib11]). However, such studies employing living pathogens on intact host plants remain challenging due to the asynchrony of the infection process at various cellular sites within the tissue.

Nevertheless, using conservative criteria for selecting differentially expressed genes in *wrky33* mutants compared to WT plants after *B. cinerea* 2100 infection, about 2600 genes were identified that showed transcriptional up- or down-regulation. The strikingly high number of modulated genes at early infection stages (14 hpi) highlights the importance of WRKY33 to initiate host responses to this pathogen.

WRKY33 regulation of **ABA** signaling is critical for host defense towards *B. cinerea* {#s3-1}
----------------------------------------------------------------------------------------

The role of ABA in biotic stress responses is complex and currently ill-defined. The ability of *Arabidopsis* to restrict penetration by the non-host barley pathogen *Blumeria graminis* was shown to be dependent on the NAC TF ATAF1-mediated repression of ABA biosynthesis ([@bib34]). In contrast, overexpression of *ATAF1* resulted in enhanced susceptibility of *Arabidopsis* plants to *B. cinerea* ([@bib81]). ATAF1 was shown to directly bind to the *NCED3* promoter, which positively correlated with increased *NCED3* expression and ABA levels ([@bib35]). Moreover, transcriptomic studies using 4-week old detached *Arabidopsis* leaves infected with *B. cinerea* strain pepper revealed that genes involved in the suppression of ABA accumulation and signaling were up-regulated at early infection stages ([@bib83]). Our study clearly demonstrates that increased expression of WRKY33 target genes associated with ABA biosynthesis (*NCED3* and *NCED5*) is causal for the susceptibility of *wrky33* to *B. cinerea* 2100, and the ABA deficient *wrky33 nced3 nced5* mutant restored WT-like resistance towards this necrotroph. Hence, our findings reveal a novel role of WRKY33 in modulating host resistance to *B. cinerea* by suppressing ABA accumulation/signaling ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). Interestingly, resistance to the necrotrophic fungus *Plectosphaerella cucumerina* is also negatively impacted by ABA, and *wrky33-1* mutant plants exhibited an enhanced susceptible phenotype towards this pathogen ([@bib74]). Stimulating *NCED3* expression and ABA biosynthesis has also been described as an important virulence strategy employed by the hemi-biotroph *P. syringae* DC3000 in *Arabidopsis* ([@bib16]). Virulence to this pathogen is strongly reduced in ABA mutants. Whether WRKY33 is involved in modulating ABA signaling during this host--bacterial interaction, and whether *P. syringae* DC3000 suppresses *WRKY33* expression is unknown.

In our experiments, the expression of several NAC TF genes associated with ABA regulation was affected upon *Botrytis* infection in a WRKY33-dependent manner. In particular, increased expression of *NAC002* (*ATAF1*)*, NAC019, NAC055, NAC061, NAC068* (*NTM1*)*,* and *NAC090* was observed in the *wrky33* mutant. Like *ATAF1*, transgenic *Arabidopsis* lines overexpressing *NAC019* or *NAC055* displayed enhanced susceptibility to *B. cinerea* ([@bib10])*.* In contrast, the *nac019 nac055* double mutant showed increased resistance to *B. cinerea* compared with WT plants. ABA has been shown to induce *NAC019* and *NAC055* expression ([@bib36]; [@bib89]). Whether any of these NAC factors, apart from ATAF1, can also target the *NCED* genes and thereby enhance ABA biosynthesis in the *wrky33* mutant remains to be tested.

ABA can repress SA-, ET-, and JA/ET-dependent signaling but also positively affect some JA responses ([@bib4]; [@bib79]). Our genetic and phytohormone studies showed that elevated ABA levels in the susceptible *wrky33* mutant resulted in concomitant increases in SA, JA, and ACC levels upon *B. cinerea* 2100 infection, implying a positive effect of ABA on these hormone signaling components. Increased SA levels per se in the *wrky33* mutant however do not contribute to susceptibility as *wrky33 sid2* double mutant plants are as susceptible to *B. cinerea* 2100 as the single mutant ([@bib8]; [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). Interestingly, concurrent increases in ABA, JA/ET and SA have also been observed in the interaction of *Arabidopsis* with *P. syringae* DC3000 and with the vascular oomycete pathogen *Pythium irregular* ([@bib1]; [@bib16]). In the case of *P. irregular,* however, host resistance correlated with high ABA levels, whereas ABA mutants were clearly more susceptible.

Our molecular analysis of *Botrytis*-challenged *wrky33* and *wrky33 nced3 nced5* plants confirmed that elevated ABA levels mainly activate NPR1-dependent SA signaling while not affecting the upstream EDS1-PAD4 pathway ([Figure 7](#fig7){ref-type="fig"}). Increased ABA also activated *ACS2*, *ACS6*, *ERF1*, and *ORA59*, targets involved in ET/JA signaling. In the *wrky33 nced3 nced5* mutant as in WT plants expression of *ACS6*, *ORA59,* but also *ERF5* and *PDF1.2* (data not shown) was significantly reduced. However, as both genotypes are resistant to *B. cinerea* these ET/JA components appear not to be essential in maintaining plant resistance.

How elevated ABA levels trigger activation of these hormone signaling cascades and specific TFs remains to be elucidated. The receptors for ABA are known ([@bib57]), but the molecular mechanisms linking downstream ABA signaling to the other hormonal pathways require further investigation. It is conceivable that the increased ABA levels in *wrky33* during *Botrytis* infection trigger the activation of currently unidentified downstream ABA-response factors that bind to the ABA response elements (ABRE, ACGTGG/T) or G-boxes (CACGTG) present in some gene promoters, resulting in transcriptional activation. Indeed, several genes including *NAC019*, *NAC061*, *FMO1*, *GH3.2*, and *GH3.3* contain such conserved motifs, which could respond to and be activated by ABA. In addition, the elevated levels of SA in *wrky33* during *Botrytis* infection may in part be responsible for the strong expression of the glutaredoxin gene *GRX480/ROXY19* observed in this mutant (RNA-seq data in this study; [@bib8]). GRX480 binds to class II TGA factors, thereby activating TGA-regulated SA responses while preventing their participation in JA-mediated signaling ([@bib87]). Plants ectopically overexpressing *GRX480* are susceptible to *B. cinerea* 2100 ([@bib8]).

WRKY33 is a dual functional transcription factor {#s3-2}
------------------------------------------------

In animals and humans, several TFs can act either as transcriptional activators or repressors, depending on DNA-binding sequences or interaction with additional co-factors ([@bib2]; [@bib6]; [@bib73]; [@bib92]). Moreover, many human TFs function as repressors as often as they act as activators ([@bib14]). In plants, few factors with dual functions have been unequivocally characterized. In tomato, the transcriptional activator Pti4 can repress the expression of *PR10-a* by forming a complex with the SEBP repressor ([@bib25]). In *Arabidopsis,* the TF WUSCHEL acts mainly as a repressor in stem cell regulation, but can function as an activator of *AGAMOUS(AG)* during floral patterning ([@bib33]). Also WRKY proteins can act as activators or repressors, and selected family members in diverse plant species have been identified as key regulators in diverse plant processes ([@bib72]). WRKY53 can activate or repress the expression of genes, depending on the nature of the target promoter sequence ([@bib56]). *WRKY6* activates *PR1* expression while suppressing the expression of its own gene, and that of its closely related family member *WRKY42* ([@bib68]). Our data show that also WRKY33 is a bi-functional TF that can act as an activator or as a repressor in a promoter-context dependent manner ([Figure 8](#fig8){ref-type="fig"}). WRKY33 positively regulates genes involved in camalexin biosynthesis such as *CYP71A13* and *PAD3* by directly binding to their promoter regions ([@bib53]; [@bib8]). Our study confirmed these observations and identified two additional camalexin biosynthetic genes, *AMT1* and *CYP71A12* that are positively and directly regulated by WRKY33 ([Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}; [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}). Mutants of *CYP71A13* and *PAD3* are susceptible to the necrotrophs *A. brassicicola* and *B. cinerea* ([@bib91]; [@bib59]). Beyond this, several *Botrytis*-induced ET response genes were targeted and positively regulated by WRKY33 ([Figure 2E](#fig2){ref-type="fig"}). Still, WRKY33 had a negative regulatory relationship on the expression of \>75% of all targets, implying that it mainly acts as a direct repressor of many defense genes following pathogen challenge.10.7554/eLife.07295.019Figure 8.Dual regulatory role of WRKY33 in modulating host defenses to *B. cinerea* 2100.WRKY33 positively regulates target genes involved in camalexin biosynthesis thereby contributing to host resistance towards *B. cinerea* 2100. Target genes involved in ET/JA biosynthesis and signaling can either be positively or negatively regulated by WRKY33. On the other hand, WRKY33 negatively regulates ABA levels by directly targeting and repressing *NCED3* and *NCED5* expression*,* or inducing expression of *CYP707A3,* a gene involved in ABA metabolism. Thus, WRKY33 has both activator and repressor functions that may depend on promoter context. Red arrows indicate positive regulation, whereas black bars indicate negative regulation. The curved red arrow highlights positive feedback regulation of WRKY33 on its own gene promoter.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.019](10.7554/eLife.07295.019)10.7554/eLife.07295.020Figure 8---figure supplement 1.Schematic representation showing WRKY33-dependent host immunity towards the necrotroph *B. cinerea* 2100 through repressing the ABA network.In WT *Arabidopsis* Col-0 plants (upper panel), *B. cinerea* inoculation induces *WRKY33* expression and protein accumulation that controls ABA levels by repressing the ABA biosynthetic target genes *NCED3* and *NCED5*, and by inducing the ABA metabolic gene *CYP707A3*. WRKY33 also directly or indirectly represses expression of other genes in different hormone signaling pathways as well as genes encoding WRKY, and NAC TFs. WRKY33 also positively affects resistance towards *B. cinerea* 2100 by directly targeting and inducing the expression of several genes involved in camalexin biosynthesis. In the *wrky33* mutant (lower panel), *B. cinerea* infection fails to activate host camalexin biosynthesis genes and increases ABA levels by up-regulation of *NCED3* and *NCED5*, which activates downstream ABA-dependent genes and ABA signaling. Among the ABA-dependent genes are genes involved in SA signaling, WRKY TFs, NAC TFs, and genes associated with auxin or JA conjugation indicating that ABA may act as a key sub-node in WRKY33-dependent host immunity to *B. cinerea*. Whereas WT-like resistance is restored in the *wrky33 nced3 nced5* triple mutant, all currently tested mutants of WRKY33-regulated genes acting downstream of ABA failed to restore resistance in the *wrky33* mutant background (marked by an asterisk). Thus, additional crucial genes causal for WRKY33-dependent resistance to *B. cinerea* 2100 remain to be discovered, as do ABA signaling components affecting *WRKY33* expression (indicated by the question marks). The solid lines with arrows indicate induction or positive modulation, the bar heads indicate suppression. Direct WRKY33 targets are indicated by the green color.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.020](10.7554/eLife.07295.020)10.7554/eLife.07295.021Figure 8---figure supplement 2.*AMT1* and *CYP71A12* expression is positively regulated by WRKY33.(**A**--**B**) IGV images of ChIP-seq data revealing high infection-dependent WRKY33 binding at the promoters of *AMT1* (**A**) and *CYP71A12* (**B**). (**C**--**D**) qRT-PCR analyses of *AMT1* (**C**) and *CYP71A12* (**D**) in WT and *wrky33* at the indicated time points after *B. cinerea* 2100 spore inoculation. qRT-PCR data were normalized to the expression of At4g26410. Error bars represent SD of three biological replicates (n = 3). Asterisks indicate significant differences between WT and *wrky33* (\*, p \< 0.05; \*\*, p \< 0.001; two-tailed *t*-test).**DOI:** [http://dx.doi.org/10.7554/eLife.07295.021](10.7554/eLife.07295.021)10.7554/eLife.07295.022Figure 8---figure supplement 3.The role of *GH3* genes in WRKY33-mediated host resistance to *B. cinerea* 2100.(**A**) Expression levels of *GH3.2* and *GH3.3* in WT and *wrky33* plants determined by qRT-PCR at the indicated time points after *B. cinerea* 2100 spore inoculation. Data were normalized to the expression of At4g26410. Error bars represent SD of three biological replicates (n = 3). Asterisks indicate significant differences between WT and *wrky33* (\*, p \< 0.05; \*\*, p \< 0.001; two-tailed *t*-test). (**B**) *B. cinerea* 2100 infection phenotypes of WT, *wrky33, gh3.2, gh3.3, gh3.2 gh3.3,* and *wrky33 gh3.2 gh3.3* plants are shown at 3 days post infection. Two 2 μl droplets containing 2.5 × 10^5^ spores were applied to each leaf.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.022](10.7554/eLife.07295.022)

How WRKY33 exerts its dual regulatory functions mechanistically requires further research. The simplest hypothesis would be that WRKY33 is recruited to distinct repressor and activator complexes at defined promoter sites. For instance, several WRKY33-interacting proteins containing a VQ motif have been discovered that influence defense gene expression ([@bib40]; [@bib12]; [@bib62]). VQ proteins appear to act as suppressors of defense-related genes via their interaction with WRKY factors. Indeed, the protein VQ4/MVQ1 appears to function as a negative regulator of WRKY-type transcriptional activators including WRKY33. In a transient *Arabidopsis* protoplast assay, stimulation by MAMPs resulted in degradation of VQ4/MVQ1 following MAPK-mediated phosphorylation enabling WRKY33 to activate transcription of a defense-related reporter gene ([@bib62]). Two other proteins, SIB1 and SIB2, have been reported to interact with WRKY33 via their VQ motifs. This interaction was required to stimulate WRKY33 DNA-binding activity and very likely to positively regulate WRKY33-mediated resistance to necrotrophic fungi ([@bib40]).

Interestingly, four VQ protein genes (*VQ8, VQ22/JAV1, VQ28, VQ33*) are also direct targets of WRKY33 and show altered expression upon *Botrytis* infection in *wrky33* compared to WT. VQ22/JAV1 functions as a negative regulator of JA-mediated defenses, and transgenic VQ22/JAV1 RNAi lines showed enhanced resistance to *B. cinerea* ([@bib31]). Thus, elevated levels of these VQ proteins in *wrky33* may contribute to the suppression of JA signaling and susceptibility to this fungus.

Finally, many members of the WRKY TF gene family, including *WRKY33* itself, are also targets of WRKY33. The majority of *WRKY* genes are transcriptionally activated during immune signaling ([@bib61]). Experimental and bioinformatics analyses have revealed that WRKY factors form a complex and highly interconnected regulatory sub-network that is positively and negatively affected by auto- and cross-regulation by various WRKY factors. This WRKY web appears to be deeply interconnected to various hormonal pathways at multiple levels, probably to ensure rapid and efficient signal amplification while allowing for tighter control in limiting the extent of the host immune response ([@bib18]; [@bib48]).

In summary, genome-wide binding analysis and transcriptional profiling have identified potential targets of WRKY33, a key transcription factor involved in mediating resistance towards the necrotroph *B. cinerea* 2100. This study revealed that genes involved in ABA biosynthesis and directly regulated by WRKY33 act at crucial nodes in this signaling cascade. Due to the complexity of the highly interconnected hormonal signaling networks targeted by WRKY33, the precise molecular mechanisms underlying this resistance remain to be fully elucidated. In this respect, global transcriptional profiling of infected *wrky33 nced3 nced5* plants should prove extremely valuable to further narrow down key genes and sub-signaling pathways required to re-establish WT-like levels of resistance in this mutant.

Materials and methods {#s4}
=====================

Plant material and growth conditions {#s4-1}
------------------------------------

For all experiments, *A. thaliana* ecotype Columbia (Col-0) was used. Besides WT, the following genotypes were employed: *wrky33* (GABI_324B11)*, nced3-2, nced5-2, nced3 nced5, aba2-12, aba3-1, cyp707a1-1, cyp707a2-1, cyp707a3-1, wrky33 sid2-1, wrky33 npr1-1, wrky33 wrky70, gh3.2, gh3.3-1.* The double or triple mutants; *wrky33 nced3, wrky33 nced5, wrky33 nced3 nced5, gh3.2 gh3.3-1,* and *wrky33 gh3.2 gh3.3* were generated by crossing single or double mutants followed by PCR-based verification using appropriate primers ([Supplementary file 6](#SD6-data){ref-type="supplementary-material"}).

Plants were grown for 4 weeks under short-day conditions in closed cabinets (Schneijder chambers: 16 hr light/ 8 hr dark cycle at 22--24°C, 60% relative humidity) on 42 mm Jiffy-7 pots (Jiffy) to prevent contaminations from garden soil. Before sewing, the Jiffy pot peat pellets were re-hydrated in water containing 0.1% liquid fertilizer Wuxal (Manna).

Pathogen inoculation procedure {#s4-2}
------------------------------

*B. cinerea* strain 2100 was cultivated on potato dextrose plates at 22°C for 10 days. Spores were collected, washed, and frozen at −80°C in 0.8% NaCl at a concentration of 10^7^ spores ml^−1^. For inoculation of *Arabidopsis* plants, the spores were diluted in Vogel buffer prepared as previously described ([@bib8]). For droplet inoculations, 2 μl of 2.5 × 10^5^ spores ml^−1^ were applied to single leaves of 4-week old intact plants. Leaves were excised from plants only for photographic documentation. The same spore concentration was used for spray inoculations of 4-week old intact plants. For mock treatment, Vogel buffer was used. Plants were kept prior to and during infection under sealed hoods at high humidity.

ChIP-seq assay {#s4-3}
--------------

4-week old WT plants or plants expressing *WRKY33-HA* from the native *WRKY33* promoter (*P*~*WRKY33*~*:WRKY33-HA*) were spray inoculated or mock treated for 14 hr. ChIP assays were performed as previously described ([@bib8]) following the modified protocol by [@bib23], using rabbit polyclonal antibodies to HA (Sigma-Aldrich, St Louis, MO). ChIP DNA was purified using a QIA quick PCR Purification kit (Qiagen, Germany) and subjected to a linear DNA amplification (LinDA) protocol ([@bib77]) which included two rounds of 'in vitro transcription' by T7 RNA polymerase. The resulting LinDA DNA was used to generate sequencing libraries bearing barcodes using a NEBNext ChIP-seq Library Pre Reagent Set for Illumina kit (New England Biolabs, Ipswich, MA). Sequencing was performed on Illumina HiSeq2500 at the Max Planck Genome Centre Cologne and resulted in about 10 million 100 bp single-end reads per sample. ChIP-qPCR validation of WRKY33 target genes was performed using gene specific primers ([Supplementary file 7](#SD7-data){ref-type="supplementary-material"}).

ChIP-seq data analysis {#s4-4}
----------------------

Before mapping, remaining LinDA adapters and low quality sequences were removed from the sequencing data using a two-step procedure. In this procedure, first Bpm and t7-Bpm sites were trimmed from the 5′ end using cutadapt (version 1.2.1) ([@bib54]) with options--e 0.2, -n 2 and--m 36 (otherwise default settings were used), and subsequently poly-A and poly-T tails and low quality ends were trimmed and reads with overall low quality or with less than 36 bases remaining after trimming were removed using PRINSEQ lite (version 0.20.2) ([@bib76]) with options--trim_qual_right/left 20, trim_tail_right/left 3 --min_len 36, -min_qual_mean 25. After this pre-processing steps, the remaining high quality reads were mapped to the *A. thaliana* reference genome TAIR10 ([http://www.arabidopsis.org](http://www.arabidopsis.org/)) using Bowtie (version 0.12.7) ([@bib41]) with options--best--m 1 to extract only uniquely mapped reads and allowing two mismatches in the first mapping steps (default settings). The ChIP-seq data sets used in this study have been deposited at the GEO repository (GSE66289).

To identify genomic DNA regions enriched in sequencing reads in the ChIP sample compared to input control as well as in inoculated compared to mock treated samples ('peak regions'), the peak calling algorithm of the QuEST program (version 2.4) ([@bib80]) was applied using the TF mode (option '2'), with permissive parameter settings for the peak calling (option '3'). Each of the two biological replicates was first analyzed separately and additionally, to obtain more exact peak locations for the consistent peaks, the mapped reads of the two replicates were pooled and peaks were also called for the pooled samples. To annotate the peak location with respect to annotated gene features in TAIR10 the annotatePeaks.pl function from the Homer suite ([@bib30]) was used with default settings. To extract consistent peaks between the replicates, a custom R ([http://www.r-project.org](http://www.r-project.org/)) function ([Source code 1](#SD9-data){ref-type="supplementary-material"}) was used that identified overlapping peak regions between the replicates. Two peak regions were counted as overlapping, if they overlapped by at least 50% of the smaller region and a peak region was counted as consistent, if it was found to be overlapping between the two individual replicates as well as the pooled sample.

To search for conserved binding motifs in the consistent WRKY33 binding regions, for each consistent peak the 500 bp sequence surrounding the peak maximum was extracted and submitted to the online version of MEME-ChIP ([@bib50]). MEME-ChIP was run with default settings, but a custom background model derived from the *Arabidopsis* genome was provided and 'Any number of repetitions' of a motif was allowed. For visualization, prominent motifs identified within MEME-ChIP by either MEME or DREME were chosen. To extract the number/percentage of peak regions that contain a certain motif, the online version of FIMO ([@bib27]) was run with the peak sequences and the motif of interest (MEME/DREME output) as input and a p-value threshold of 0.001.

RNA-seq assay {#s4-5}
-------------

Total RNA was extracted from mock treated (14 hpi) and *B. cinerea* infected (14 hpi) 4-week old plants (WT and *wrky33*) using the RNeasy Plant Mini kit (Qiagen) according to the manufacturer\'s instructions, and mRNA sequencing libraries were constructed with barcodes using the TrueSeq RNA Sample Preparation Kit (Illumina). Three biological replicates were sequenced on Illumina HiSeq2500 by the Max Planck Genome Centre Cologne, resulting in 25--45 million 100 bp single end reads per sample. Total reads were mapped to the *Arabidopsis* genome (TAIR10) under consideration of exon-intron structures using the splice-aware read aligner TopHat (version 2.0.10) ([@bib38]) with settings--a 10 --g 10 and known splice sites provided based on TAIR10 gene annotations. The RNA-seq data sets used in this study have been deposited at the GEO repository (GSE66290).

Statistical analysis of RNA-seq {#s4-6}
-------------------------------

The mapped RNA-seq reads were transformed into a count per gene using the function coverageBed of the bedTools suite ([@bib66]) with option--split to consider exon-intron structures. Genes with less than 50 reads in all samples together were discarded, and subsequently the count data of the remaining genes were TMM-normalized and log2-transformed using functions 'calcNormFactors' (R package EdgeR) ([@bib70]) and 'voom' (R package limma) ([@bib42]). To analyze differential gene expression between genotypes (WT, *wrky33*) and treatments (mock treated, *B. cinerea* infected), we fitted a linear model with the explanatory variable 'genotype_treatment' (i.e., including both genotype and treatment) using the function lmFit (R package limma). Subsequently, we performed moderated t-tests over the four contrasts of interest. Two contrasts compare *B. cinerea* infected vs mock treated samples within each genotype and the other two contrasts compare *wrky33* vs WT Col-0 plants within each treatment. In all cases, the resulting p values were adjusted for false discoveries due to multiple hypothesis testing via the Benjamini--Hochberg procedure. For each contrast, we extracted a set of significantly differentially expressed genes between the tested conditions (adj. p value ≤ 0.05, \|log2FCΙ ≥ 1).

Gene ontology analysis {#s4-7}
----------------------

GO term enrichment analysis on the gene sets of interest was performed using the R package goseq ([@bib85]) with custom GO term mappings obtained from org.At.tairGO2ALLTAIRS within the R package org.At.tair.db ([@bib95]). To identify enriched GO terms, the Wallenius distribution was used to approximate the null distribution and a probability weighting function was applied to correct for potential count biases in the analyzed gene sets. The resulting p values were adjusted for false discoveries due to multiple hypothesis testing via the Benjamini-Hochberg procedure and for each subset the significantly over-represented GO terms were extracted (adj. p value \< 0.05). For the set of all WRKY33-regulated targets, the R package topGO ([@bib94]) was used to visualize the GO sub-graphs induced by the 10 most significantly enriched GO terms in the category 'Biological Process' and the five most significantly enriched GO terms in the category 'Molecular Function', respectively.

qRT-PCR {#s4-8}
-------

Total RNA was isolated from leaves at 8, 14, 24, and 48 hpi with *B. cinerea* spores as described above and reverse transcribed with oligo(dT) primer to produce cDNA using the SuperScript First-Strand System for Reverse-Transcription PCR following the manufacturer\'s protocol (Invitrogen, Grand Island, NY). cDNAs corresponding to 2.5 ng of total RNA were subjected to qPCR with gene-specific primers ([Supplementary file 8](#SD8-data){ref-type="supplementary-material"}) using the SYBR Green reagent (Bio-Rad, Hercules, CA). The qPCRs were performed on the iQ5 Multicolor Real-Time PCR Detection System (Bio-Rad) with three biological replicates. The relative expression was normalized to At4g26410 that was described as being highly constant under varying stress conditions ([@bib15]). Data shown are means ± SD from the three biological replicates.

Phytohormone measurements and quantification {#s4-9}
--------------------------------------------

Sample processing, data acquisition, instrumental setup, and calculations were performed as described ([@bib93]). Instrument specific parameters for the detection of SA are shown in the Table below. (3,4,5,6-D~4~)-SA was obtained from Campro Scientific (Veenendal, The Netherlands) and used as internal standard for SA quantification (1.5 ng per sample).

MS parameters for MRM-transition of salicylic acids (SA).HormoneMRM transitionsDeclustering potential (DP), VEntrance potential (EP), VCell entrance potential (CEP), VCollision potential (CE), VCell exit potential (CEX), VSA**137 → 93**−25−5.5−14−220*137* *→* *65*−25−5.5−14−440SA-D~4~**141 → 97**−25−5.5−14−220[^2]

Quantification of fungal growth by qPCR {#s4-10}
---------------------------------------

Quantification of fungal biomass relative to plant biomass by qPCR was basically performed as previously described ([@bib22]). Leaves of the indicated *Arabidopsis* lines were inoculated with two 2 μl droplets of *B. cinerea* spores and DNA extracted 3 days later from whole leaves of similar fresh weight. The relative amounts of *B. cinerea* and *Arabidopsis* DNA were determined by qPCR employing specific primers for cutinase A and SKII, respectively.

Expression of recombinant WRKY33 protein and EMSA {#s4-11}
-------------------------------------------------

Full-length WRKY33 protein fused with NusA and an 8xHis-tag was expressed in the vector pMCSG48 in the *Escherichia coli* strain BL21 (DE3) Magic (kindly provided by Dr Michal Sikorski and Marta Grzechowiak, Institute of Bioorganic Chemistry, Poznan, Poland). Bacteria containing the *WRKY33* expression construct or the empty vector were induced with 0.5 mM isopropylthio-β-galactisude for 3 hr at 18°C. The His-tagged protein was purified using nickel affinity columns (QIAexpress Ni_NTA Fast Start, Qiagen, Germany) following the instructions of the manufacturer, and subsequently dialyzed against 20 mM Tris--HCl, pH 7, 5 overnight at 4°C.

The following DNA oligonucleotide probes were synthesized and biotin labeled by Sigma--Aldrich (Germany): W-box probe, 5′-CG[TTGACC]{.ul}G[TTGACC]{.ul}GAG[TTGACT]{.ul}TTTTA-3′; W-boxmut, 5′-CGTTGA[A]{.ul}CGTTGA[A]{.ul}CGAGTTGA[A]{.ul}TTTTTA-3′; M-3, 5′-AA[TTTGAAT]{.ul}AATCAAAGATCTTCC[TTTGAAT]{.ul}TACCT[ATTCAAC]{.ul}AT-3′ (derived from the *PROPEP3* promoter sequence); and M-7, 5′-GTCCACGCTTG[TTTGAAT]{.ul}TTTCAGCCTTTGCAGGCAAGGT-3′ (derived from the *WAKL7* promoter sequence). Two complementary strands of the oligonucleotides were annealed by heating probes to 95°C for 3 min and then allowing probes to cool to room temperature overnight. Freshly prepared recombinant WRKY33 protein (1 μg) was incubated with the DNA probe (20 fmol) for 20 min at room temperature using the LightShift Chemiluminescent EMSA kit (Thermo Fisher, Germany) in the presence or absence of unlabeled competitor DNA. The resulting protein-DNA complexes were electrophoresed on 5% (wt/vol) polyacrylamide gels, and then transferred to N^+^ nylon membranes in 0.5% Trisborate/EDTA buffer at 380 mA at 4°C for 60 min. Biotin labeled DNA detection was done according to the instructions of the manufacturer (Thermo Fisher). Bands were visualized using the BioRAD ChemiDoc MP Imaging System.
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--------------

The following datasets were generated:

Liu S, Birkenbihl RP, Somssich IE, Kracher B, 2015,WRKY33-dependent expression of Arabidopsis genes upon Botrytis cinerea 2100 inoculation,<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66290>,Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSE66290).

Liu S, Birkenbihl RP, Somssich IE, Kracher B, 2015,WRKY33 binding sites in Arabidopsis upon Botrytis cinerea 2100 inoculation,<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66289>,Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSE66289).

Liu S, Birkenbihl RP, Somssich IE, Kracher B, 2015,Analysis of WRKY33 binding sites and WRKY33-dependent gene expression in Arabidopsis thaliana upon Botrytis cinerea 2100 inoculation,<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=gnmxuwmqdlilfcz&acc=GSE66300>,Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSE66300).
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "Negative regulation of ABA signaling is critical for WRKY33-dependent *Arabidopsis* immunity towards *Botrytis cinerea*" for consideration at *eLife*. Your article has been in principle favorably evaluated by Detlef Weigel (Senior editor), a Reviewing editor, and two reviewers.

The Reviewing editor and the reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

The reviewers agreed that your work identifying new WRKY33 targets during *Botrytis* infection is very interesting. The work nicely showed that you pinpointed new players in WRKY33-mediated resistance. Specifically, you reported that ABA (not SA) is a major player in WRKY33-activated resistance. While we are in principle supportive, there are some specific issues that need to be addressed to strengthen the work and acceptable for publication.

1\) 1684 WRKY33 binding sites from genomic regions were associated with 1567 genes using ChIP-seq. Of them, 76% were W-box motifs which were consistent with previously reported WRKY family TF-binding sites. Moreover, you identified a new motif not previously known to bind WRKY factors, T/GTTGAAT. We think this is one of the major novelties of this study, but additional evidence needs to be provided to determine whether this is mediated by direct binding, or by other factors. If this motif is functionally as important as the W-box motif, the genomic regions containing such motifs should be undergoing evolutionary selection and their sequences should be conserved. We suggest that you compare the genomic regions containing W-box motif and/or T/GTTGAAT motif with the reported conserved DNA elements as described in Haudry et al. (2013)(PubMed ID: 23817568). Important WRKY33 target genes, such as *NCED* genes, would be expected to be associated evolutionarily conserved DNA elements.

2\) For at least a couple of evolutionarily conserved T/GTTGAAT motifs, it is desirable to use a method like EMSA to test for direct binding. Alternatively, the authors might design artificial reporters with multiple tandem motif repeats alone or in combination with W boxes to test their regulatory activities (using constructs with single or double tandem motif repeats or truncated motifs as a control). This could be done as shown in a recent study (Li et al. Plant Cell 2015; PubMed ID: 25691733).

3\) It has been known that TF-binding sites have dosage effects. For the TF-binding sites with positive regulation activities, multiple copies of motifs or binding signals on promoter regions are often associated with higher transcriptional induction levels. We suggest the authors to carry out a genome-wide correlation analysis between the binding signals/motif numbers and expression fold-changes for all the WRKY33 positively regulated target genes. This is feasible since the authors already have the ChIP-seq and RNA-seq datasets in hand.

4\) Please clarify whether you normalized the gene expression levels on the basis of Per Kilobase of exon model per Million mapped reads (FPKM). Were exon-intron structures considered? If so, please describe this in the Materials and methods section. Otherwise, such expression level analysis may have bias on the genes with longer exons, which may further result in false positive detection during GO enrichment analysis. We suggest the authors use CuffDiff and/or DESeq2 to calculate Per Kilobase of exon model per Million mapped reads (FPKM) for all the TAIR0 genes and normalize their expression levels as described by Trapnell et al. 2012 (PubMed ID: 22383036).

10.7554/eLife.07295.033

Author response

*1) 1684 WRKY33 binding sites from genomic regions were associated with 1567 genes using ChIP-seq. Of them, 76% were W-box motifs which were consistent with previously reported WRKY family TF-binding sites. Moreover, you identified a new motif not previously known to bind WRKY factors, T/GTTGAAT. We think this is one of the major novelties of this study, but additional evidence needs to be provided to determine whether this is mediated by direct binding, or by other factors. If this motif is functionally as important as the W-box motif, the genomic regions containing such motifs should be undergoing evolutionary selection and their sequences should be conserved. We suggest that you compare the genomic regions containing W-box motif and/or T/GTTGAAT motif with the reported conserved DNA elements as described in Haudry et al. (2013)(PubMed ID: 23817568). Important WRKY33 target genes, such as* NCED *genes, would be expected to be associated evolutionarily conserved DNA elements*.

As suggested by the reviewers, we have checked whether the T/GTTGAAT motif is contained in the conserved noncoding sequences (CNS) described by Haudry et al. (2013) (PubMed ID: 23817568). The W-box motif has already been reported to be a conserved DNA element in that previous publication. Our analysis found that both the W-box and the T/GTTGAAT motifs that are located within our WRKY33 ChIP peak regions tend to be associated more strongly with CNS than the corresponding motifs outside of WRKY33 ChIP peaks. Still, overall the T/GTTGAAT motif is less common in the At genome, seems to be less enriched in CNS in general and also the association with CNS observed for motifs within WRKY33 ChIP peaks is clearly less pronounced than for the W-box. Taken together, we think that our exploratory analyses do not sufficiently support that this T/GTTGAAT motifs is strongly conserved and therefore undergoing evolutionary selection (if requested by the reviewers we can also supply the detailed results of our analyses). Thus, we feel at this stage we should not speculate too much on this point and therefore also are reluctant to include it in our manuscript.

In the course of re-analyzing our data realized there was an error in our previous Venn diagram ([Figure 1--figure supplement 1D](#fig1s1){ref-type="fig"}). This error has no impact on our earlier conclusions but rather affect only absolute number of overlapping peaks.

*2) For at least a couple of evolutionarily conserved T/GTTGAAT motifs, it is desirable to use a method like EMSA to test for direct binding. Alternatively, the authors might design artificial reporters with multiple tandem motif repeats alone or in combination with W boxes to test their regulatory activities (using constructs with single or double tandem motif repeats or truncated motifs as a control). This could be done as shown in a recent study (Li et al. Plant Cell 2015; PubMed ID: 25691733)*.

We performed EMSA to address whether the newly identified element could be bound by WRKY33. For this we used as a positive control an oligonucleotide (designated W-box) containing 3 W-box motifs that has previously been shown by Mao et al. (Plant Cell 23, 1639-1653, 2011) to be bound by WRKY33 in EMSA, and as a negative control for binding specificity a similar oligonucleotide (designated W-boxmut), in which the TGAC core motif of the three W-boxes was mutated to TGAA. We synthesized two oligonucleotides containing the new motif (T/GTTGAAT) that were derived from two promoter sequences that we identified as WRKY33 targets in our ChIP-seq studies, and that resided within WRKY33 binding regions. One 45 bp oligonucleotide (designated M-3) was deduced from the *PROPEP3* gene promoter (At5g64905) and contained three copies of this new motif, and a second 40 bp oligonucleotide (designated M-7) derived from the *WAKL7* gene promoter (At1g16090), which contained one copy. WAKL7 was included because this promoter contains no W-box motifs within its entire promoter but still showed strong enrichment of WRKY33 in our ChIPseq and ChIP-qPCR assays. The results of this study are now included as [Figure 1--figure supplement 2](#fig1s2){ref-type="fig"}, and they clearly show that WRKY33 does not directly bind to the new motif. Moreover, this motif is also not capable of competing for W-box binding. Mention of these results was also added to the text (subsection headed "Genome-wide detection of *Arabidopsis* WRKY33 binding sites in response to *B. cinerea* 2100") and description of the experiment was added to the Materials and methods section.

*3) It has been known that TF-binding sites have dosage effects. For the TF-binding sites with positive regulation activities, multiple copies of motifs or binding signals on promoter regions are often associated with higher transcriptional induction levels. We suggest the authors to carry out a genome-wide correlation analysis between the binding signals/motif numbers and expression fold-changes for all the WRKY33 positively regulated target genes. This is feasible since the authors already have the ChIP-seq and RNA-seq datasets in hand*.

As suggested by the reviewers we have performed genome-wide correlation analysis to test whether the number of the motifs (W-box, new motif, both motifs) present in a peak is correlated to the observed expression fold-changes of WRK33-induced target genes. This analysis did not reveal a clear positive correlation between motif number and gene induction (Spearman\'s rho between 0.071 and 0.273).

However, we are aware that only one *B. cinerea* induced time-point (14hpi) was selected for RNA-seq analysis. Thus, it is conceivable that the expression of various WRKY33 induced target genes have not yet reached or have already passed their expression maxima. We believe that without performing temporal expression studies no clear statement related to this point can be made.

*4) Please clarify whether you normalized the gene expression levels on the basis of Per Kilobase of exon model per Million mapped reads (FPKM). Were exon-intron structures considered? If so, please describe this in the Materials and methods section. Otherwise, such expression level analysis may have bias on the genes with longer exons, which may further result in false positive detection during GO enrichment analysis. We suggest the authors use CuffDiff and/or DESeq2 to calculate Per Kilobase of exon model per Million mapped reads (FPKM) for all the TAIR0 genes and normalize their expression levels as described by Trapnell et al. 2012 (PubMed ID: 22383036)*.

As the reviewers note, in RNA-seq analysis it is important to consider exon-intron structures. We have done so by using Tophat for the read alignment, which is a read-mapping tool that can map across and also identify splice junctions. And we also considered exon-intron structures when extracting the read counts per gene by using coverageBed with the option--split. As suggested by the reviewers we have now slightly rephrased the corresponding paragraphs in the Material and methods section to better clarify this.

In our subsequent differential expression analysis we have applied another accepted normalization approach, the so-called TMM (weighted trimmed mean of M-values \[i.e. log fold changes\]) normalization as proposed by Robinson and Oshlack (2010) (PubMed ID: 20196867). This normalization approach has been shown before e.g. by Dillies at al., 2012 (PubMed ID: 22988256) to be more efficient than the classic RPKM/FPKM normalization (at least when used without application of further scaling as done e.g. in newer versions of CuffDiff) and comparable to the normalization method used in DESeq/DESeq2. This TMM normalization was combined with a log2 transform to yield log2-counts per million (log2cpm) using the function 'voom' in the R package limma, which additionally estimates the mean-variance relationship for the log-counts and assigns a weight to each observation based on its predicted variance. These weights are then used in the subsequent linear modeling process to adjust for heteroscedasticity as described by [@bib42] (PubMed ID: 24485249). This normalization procedure and subsequent linear modeling in limma (voom-limma) have been shown previously e.g. by Rapaport et al., 2013 (PubMed ID: 24020486) and Seyednasrollah et al., 2013 (PubMed ID: 24300110) to perform well at detecting differentially expressed genes on different datasets with respect to both sensitivity and specificity (also when compared with CuffDiff), and to be among the best tools when the number of replicates is relatively low, like with the three replicates we are analyzing.

We are aware that this approach also has its limitations, for example it considers expression at the gene level without regard to the potential isoform diversity and there might be certain specific cases where this gene-level analysis might not be able to correctly identify differential expression (for genes with both up-regulated and down-regulated isoforms). The suggested tool CuffDiff addresses this problem by combining the differential expression analysis with isoform deconvolution and is a reasonable and thus widely used alternative. However, we believe that the estimation of isoform-specific expression is a very difficult task, especially for genes with strongly overlapping isoforms and at moderate sequencing depths, and accordingly any isoform-specific expression estimates inevitably are associated with a certain degree of uncertainty. Overall, we think both approaches have their strengths and weaknesses, and, at least for the analysis of gene-level expression differences we are focusing on in this study, our workflow is just as much a reasonable approach as the suggested CuffDiff.

Nevertheless, to further verify the reliability of our results, we re-analyzed our RNA-seq data with both suggested alternative tools (DESeq2 and CuffDiff). A comparison of the gene sets identified with each tool as significantly differentially expressed (absolute log2FC ≥ 1, p \< 0.05) for the four analyzed contrasts showed a large overlap between the gene sets. The vast majority of differentially expressed (DE) genes identified with our workflow (limma) were also identified as DE with DESeq2, and, to a slightly lesser extent, also with CuffDiff, with a major fraction of genes being consistently identified with all three tools ([Author response image 1](#fig9){ref-type="fig"}). Similarly, also comparisons of the observed log2 fold changes between the tools showed an extremely high correlation between our workflow (limma) and DESeq2 ([Author response image 2](#fig10){ref-type="fig"}) and still also a strong correlation between our workflow and CuffDiff ([Author response image 3](#fig11){ref-type="fig"}) in spite of the conceptual differences between the tools. This strong agreement between the three tools in our view confirms the overall reliability of our results and supports our judgment that the workflow we used in our analysis is also a valid alternative to identify differentially expressed genes. As suggested by the reviewers, we have now rephrased the corresponding section in the Material and methods to describe the used approach in a bit more detail.10.7554/eLife.07295.034Author response image 1.Venn diagrams showing the overlap between the sets of genes identified as significantly differentially expressed (abs(log2FC) ≥ 1, p adj \< 0.05) with the three different tools limma (used in our study), DESeq2 and Cuffdiff for the four analysed comparisons.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.034](10.7554/eLife.07295.034)10.7554/eLife.07295.035Author response image 2.Plots show the correlation between the log2 fold changes obtained for each gene with limma (used in our study) and the alternative tool DESeq2. Yellow points represent genes identified with limma as significantly DE (p adj \< 0.05), blue circles represent genes identified with DESeq2, and an overlap of both marks represents genes consistently identified with both tools.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.035](10.7554/eLife.07295.035)10.7554/eLife.07295.036Author response image 3.Plots show the correlation between the log2 fold changes obtained for each gene with limma (used in our study) and the alternative tool Cuffdiff. Yellow points represent genes identified with limma as significantly DE (p adj \< 0.05), blue circles represent genes identified with Cuffdiff, and an overlap of both marks represents genes consistently identified with both tools.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.036](10.7554/eLife.07295.036)

Still, it has been shown before, as the reviewers point out, that the detection of differentially expressed genes can have a bias on genes with longer exons or more general on genes with higher read counts. We also agree with the reviewers that the potential existence of such a bias would in turn result in a bias in the downstream GO term enrichment analysis. Thus, we explicitly checked our DE sets for the presence of such a bias, and an analysis of the gene length distributions did not reveal any evidence for a bias toward longer genes in our DE gene sets, also when compared to the DE gene sets obtained with the suggested alternative tool CuffDiff ([Author response image 4](#fig12){ref-type="fig"}). However, the observed read counts in an RNA-seq experiment can be biased not only by differences in transcript length, but also by further factors like differences in sequence composition or secondary structure. Moreover, the gene set on which we actually performed the GO enrichment analysis contained only the subset of DE genes (wrky33 "regulated") that were also found to be bound in our ChIP-seq (wrky33 "targets"), and it has been shown that also the identification of ChIP-seq targets can have a bias on more highly expressed genes. Thus, we additionally checked our specific gene sets of interest ("regulated", "targets", "regulated targets") for the presence of an expression bias in general ([Author response image 5](#fig13){ref-type="fig"}). As the ChIP-seq targets did indeed seem to have a certain bias towards higher expressed genes, we re-did the GO term enrichment analysis with a different tool (goseq) that can account for this potential expression bias in the analyzed gene set through the integration of a probability weighting function. In this way we can, within the GOterm analysis itself, correct for any expression bias in the analyzed gene set and thus reduce the chance of false positive detections. We have updated the corresponding text and figures ([Figure 2E](#fig2){ref-type="fig"}, [Figure 2--figure supplement 1](#fig2s1){ref-type="fig"}) in our manuscript to now represent the results of this new GO term analysis with expression bias correction (which overall agree quite well with the previous analysis) and also adjusted the methods description accordingly.10.7554/eLife.07295.037Author response image 4.Boxplots represent the gene length distributions among the set of all analyzed genes and the subsets of genes identified as significantly differentially expressed (with abs(log2FC) ≥ 1, p adj \< 0.05) in the four analyzed pairwise comparison with the voom-limma workflow used in our study (A) or the alterantive tool Cuffdiff (B).**DOI:** [http://dx.doi.org/10.7554/eLife.07295.037](10.7554/eLife.07295.037)10.7554/eLife.07295.038Author response image 5.Boxplots represent the distributions of total read counts (over all samples together) per gene among the set of all analysed genes and the subsets of wrky33-regulated genes (from RNA-seq), wrky33 targets (from ChIP-seq) and wrky33-regulated wrky33 targets.**DOI:** [http://dx.doi.org/10.7554/eLife.07295.038](10.7554/eLife.07295.038)
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